Boeing, Intellia Therapeutics, Royal Caribbean and more

Boeing, Intellia Therapeutics, Royal Caribbean and more

Intellia shares surged 50% after the company announced positive results from a phase one study, along with partner Regeneron, of a gene-editing treatment. The treatment is the first time gene-editing technique CRISPR has been delivered systemically as a medicine to the human body. Other companies involved with CRISPR also saw their shares rally, with CRISPR Therapeutics’ stock soaring 6.4% and Editas Medicine’s stock jumping 5%.Boeing — Shares fell 3.4% after the Federal Aviation Administration said in a letter to the aircraft maker that its 777X long-range aircraft likely won’t be approved to fly until mid- to late-2023 at the earliest. The FAA’s letter to Boeing, which was obtained by CNBC, said there were numerous technical issues that needed to be resolved.Cruise stocks — Cruises may be back, but cruise line stocks are falling after two teenage guests on one of Royal Caribbean’s ships tested positive for Covid-19. Royal Caribbean traded 6.4% lower Monday, while Carnival fell 7% and Norwegian Cruise dropped 6%.Oil stocks — Oil names fell as West Texas Intermediate crude oil futures dipped Monday after gaining more than 10% in June. Occidental Petroleum erased 5%, Marathon Oil dropped 4.8%, Devon Energy shed 4.5% and Chevron fell 3% lower.Tesla — Shares gained 2.5% after Wedbush said the company faces a “moment of truth” following an autopilot software recall in China. The firm maintained its outperform rating on the electric vehicle maker despite the negative headlines.Nvidia — The semiconductor maker saw its equity jump 5% after it received support for its planned $40 billion takeover of U.K.-based chip designer Arm, according to a report in the Sunday Times of London. The public display of support comes from Broadcom, Marvell and MediaTek, all of which are customers of Arm.NRG Energy — The utility stock jumped more than 6% after Goldman Sachs added NRG Energy to its conviction list. The firm said in a note to clients that NRG’s strong cash flow profile could enable the company to buy back nearly a quarter of its shares.Perion Network — Shares jumped 17% after the Israel-based ad-tech company reported better-than-expected preliminary second-quarter results. The company reported preliminary second-quarter revenue of $105 million, compared with analysts’ projection of $95.9 million, according to FactSet.Bed Bath & Beyond — The retailer’s stock traded more than 5.9% higher after CFRA Research upgraded it to a buy rating from hold. CFRA said it’s maintaining a $40 price target, implying almost 40% upside.— CNBC’s Jesse Pound, Tom Franck and Tanaya Macheel contributed reporting

News source :- CNBC

Leave a Reply

Your email address will not be published. Required fields are marked *

Report News
Google